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Abstract
In order to determine the contribution of a-thalassemia to microcyto-
sis and hypochromia, 339 adult outpatients seen at Unicamp Univer-
sity Hospital (with the exception of the Clinical Hematology outpa-
tient clinics), who showed normal hemoglobin (Hb) levels and re-
duced mean corpuscular volume and mean corpuscular hemoglobin,
were analyzed. Ninety-eight were Blacks (28.9%) and 241 were
Caucasians (71.1%). In all cases, Hb A2 and F levels were either
normal or low. The most common deletional and nondeletional forms
of a-thalassemia [-a3.7, -a4.2, --MED, -(a)20.5, aHphIa, aNcoIa, aaNcoI and
a
TSAUDI] were investigated by PCR and restriction enzyme analyses. A
total of 169 individuals (49.9%) presented a-thalassemia: 145 (42.8%)
were heterozygous for the -a3.7 deletion (-a3.7/aa) and 18 (5.3%)
homozygous (-a3.7/-a3.7), 5 (1.5%) were heterozygous for the
nondeletional form aHphIa (aHphIa/aa), and 1 (0.3%) was a --MED
carrier (--MED/aa). Among the Blacks, 56 (57.1%) showed the -a3.7/
aa genotype, whereas 12 (12.2%) were -a3.7/-a3.7 and 1 (1.0%) was an
a
HphI
a carrier; among the Caucasians, 89 (36.9%) were -a3.7/aa, 6
(2.5%) had the -a3.7/-a3.7 genotype, 4 (1.7%) presented the nondeletional
form (aHphIa/aa), and 1 (0.4%) was a --MED carrier. These results
demonstrate that a-thalassemia, mainly through the -a3.7 deletion, is
an important cause of microcytosis and hypochromia in individuals
without anemia. These data are of clinical relevance since these
hematological alterations are often interpreted as indicators of iron
deficiency.
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Introduction
Microcytosis and hypochromia result
from deficient hemoglobin (Hb) synthesis in
erythroid cells, causing a reduction in both
mean corpuscular volume (MCV) and mean
corpuscular hemoglobin (MCH) of red blood
cells. Without the increase in Hb A2 levels,
these hematological alterations may be due
to a-thalassemia, iron deficiency or, occa-
sionally, chronic disease anemia (1,2).
a-Thalassemia is the most common ge-
netic disorder of Hb synthesis in the world,
with gene frequencies varying between 1%
and 98% throughout the tropics and subtrop-
ics, where Plasmodium falciparum is or has
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been endemic, or in populations which re-
ceived people from these areas through im-
migration (3-5). It results from an imbalance
in a-globin chain production, which can be
reduced (a+-thalassemia) or completely abol-
ished (a0-thalassemia). Most commonly a-
thalassemia results from deletion of one (-a)
or both (--) of the duplicated a genes (aa) on
chromosome 16p13.3. Less frequently, it is
caused by small deletions or point mutations
(so-called nondeletional a-thalassemia) in-
volving the predominantly expressed a2 gene
(aTa) or rarely the a1 gene (aaT), or yet by
deletions outside the a cluster which leave
the structural genes intact but without ex-
pression (3,6).
The a-thalassemia phenotypes range from
mild microcytic hypochromic anemia to a
hemolytic anemia of variable severity char-
acterized by the presence of Hb H in the case
of loss of three functional a genes, or to the
hydrops fetalis syndrome, characterized by
severe intrauterine anemia and fetal or peri-
natal death due to the loss of all four a globin
genes (1-3). The most common cause of a-
thalassemia is a deletion of 3.7 kb of DNA
originated by homologous recombination
between misaligned chromosomes, which
affects both a genes in cis and results in a
unique hybrid gene (a2a1) (-a3.7 deletion).
The hematological alterations caused by this
deletion, also known as rightward a+-thalas-
semia, can be very mild, if not silent (7-9). It
is most prevalent in the African and Mediter-
ranean regions. Other relatively frequent
causes of a-thalassemia are the -a4.2 dele-
tion (leftward a+-thalassemia) found in Asian
and Mediterranean populations, the --MED
and -(a)20.5 deletions, common causes of a0-
thalassemia in the Mediterranean region, and
the --SEA deletion, found with high frequency
in Southeast Asia (7). Among the most com-
mon nondeletional forms, aHphIa is a penta-
nucleotide deletion in the splice donor site of
IVS-I which abolishes a HphI site in the a2
gene; aNcoIa and the aaNcoI are caused by
base substitutions in the translational initia-
tion codon ATG in the a2 or in the a1 gene,
respectively, which presumably completely
abolish translation and can be recognized by
the loss of the NcoI site present in the initia-
tion codon, and a third mutation, aTSAUDIa,
caused by a base substitution in the highly
conserved polyadenylation signal sequence
AATAAA, which must prevent endonucle-
olytic cleavage and poly A addition to the 3
end of mRNAs (7). They are all encountered
in Mediterranean populations. In Brazil, the
-a3.7 deletion has been frequently found in
the Black population (10,11), and the --MED
and -(a)20.5 deletions have sporadically been
described (12,13). One family with the
nondeletional form aHphIa has been recently
reported (13).
Individuals with microcytosis and hypo-
chromia, without anemia, have been detected
in clinical laboratories. In order to determine
the contribution of a-thalassemia to such
cases, we analyzed 339 adult individuals,
followed as outpatients at Unicamp Univer-
sity Hospital (with the exception of the Clini-
cal Hematology outpatient clinics), who
showed normal Hb levels together with re-
duced MCV and MCH and normal or de-
creased Hb A2 (and F).
Material and Methods
Subjects
A total of 339 adult individuals (age >14
years), followed as outpatients at Unicamp
University Hospital, Campinas, State of Sªo
Paulo, Southeast Brazil, with the exception
of the Clinical Hematology outpatient clin-
ics, were analyzed. The subjects presented
normal Hb levels (Hb ³14 g/dl for men and
³12 g/dl for women) and reduced MCV (£80
fl) and MCH (£27 pg). Ninety-eight indi-
viduals were Blacks (28.9%), including
Mulattoes and Negroes, and 241 were Cau-
casians (71.1%). In all cases, Hb A2 and F
levels were normal or decreased (<3.6 and
<2.0%, respectively).
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The patients studied here formally con-
sented to be investigated for the presence of
a-thalassemia.
Methods
Red blood cell indices were electroni-
cally determined (Cell Dyn 3500, Abbott
Laboratories, Chicago, IL, USA), and Hb
analyses were carried out according to
Weatherall and Clegg (1).
DNA samples were obtained from pe-
ripheral blood leukocytes by organic extrac-
tion. With the exception of the --SEA deletion,
all the other deletional and nondeletional
forms of a-thalassemia mentioned above
were investigated by PCR-based methods.
Rightward deletion (-a3.7) was detected by
the method of DodØ et al. (14); --MED and
-(a)20.5 were investigated as described by
Bowden et al. (15), and the -a4.2 leftward
deletion was screened by the method of Oron-
Karni et al. (16). Nondeletional forms were
investigated according to Hall et al. (17)
using the corresponding restriction enzymes
(HphI and NcoI) and a specific nested PCR
for aTSAUDI (15).
Serum ferritin levels were determined by
an automated chemoluminescent immuno-
enzymatic method (Immulite, Diagnostic
Products Co., Los Angeles, CA, USA) for all
a-thalassemic cases to make sure that micro-
cytosis and hypochromia were not due to
concomitant iron deficiency.
Results
The results are summarized in Table 1.
Among the 339 individuals studied, 169
(49.9%) presented a-thalassemia: 145
(42.8%) were heterozygous for the -a3.7 de-
letion (-a3.7/aa), 18 (5.3%) were homozy-
gous (-a3.7/-a3.7), 5 (1.5%) showed the
nondeletional form aHphIa/aa, and 1 (0.3%)
was a  --MED carrier (--MED/aa). Among the
98 Blacks, 56 (57.1%) showed the -a3.7/aa
genotype, while 12 (12.2%) were -a3.7/-a3.7
and 1 (1.0%) was aHphIa/aa; among the
Caucasians, 89 (36.9%) were -a3.7/aa, 6
(2.5%) had the -a3.7/-a3.7 genotype and 4
(1.7%) were aHphIa/aa. The --MED carrier
belonged to this racial group (0.4%).
The serum ferritin levels determined for
the a-thalassemia cases were all above the
lower normal limits (9 ng/ml for women and
19 ng/ml for men).
Discussion
The present results demonstrated that a-
thalassemia, mainly through the -a3.7 dele-
tion, is an important cause of microcytosis
and hypochromia in individuals without ane-
mia, indicating that non-anemic Brazilian
Blacks, with low MCV and MCH, have a
70.4% chance of carrying a-thalassemia,
whereas this chance is of 41.5% among Bra-
zilian Caucasians, i.e., still high. The -a3.7
deletion is known to occur at significant
frequencies in Black populations (7). Since
in Brazil there is an elevated degree of mis-
cegenation, it seems that even in the non-
Black population its prevalence is also high.
The present data are of clinical relevance,
since microcytosis and hypochromia are of-
ten interpreted as indicators of iron defi-
ciency and patients may be mistreated with
oral iron therapy (18). In about 50% of the
cases analyzed here, the cause of these he-
matological alterations was a-thalassemia.
It is possible that this proportion is still a
little higher, because many silent mutations
Table 1. Genotypes found among 339 individuals with microcyto-
sis and hypochromia without anemia.
Caucasians Blacks Total
aa/aa 141/241 (58.5%) 29/98 (29.7%) 170 (50.1%)
-a3.7/aa 89/241 (36.9%) 56/98 (57.1%) 145 (42.8%)
-a3.7/-a3.7 6/241 (2.5%) 12/98 (12.2%) 18 (5.3%)
a
HphI
a/aa 4/241 (1.7%) 1/98 (1.0%) 5 (1.5%)
--MED/aa 1/241 (0.4%) - 1 (0.3%)
Total 241 (71.1%) 98 (28.9%) 339 (100%)
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causing a-thalassemia and other not so com-
mon deletions may not have been detected.
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